Patient Centricity: Joining Qualitative with Quantitative
Patient Centricity: Joining the Qualitative with the Quantitative By Monica St Claire Reams of market research and data can provide insight, but so can one patient in the room, telling you [...]
Doing Better and Feeling Worse: Patients with Long-term Conditions Describe Treatment Side Effects
Doing Better and Feeling Worse: Patients with Long-term Conditions Describe Drug Side Effects By Kathleen Hoffman, PhD, MSPH We live in fortunate times; people are now described as “living with” conditions. [...]
Getting the Real Story from Patients
Getting the Real Story from Patients By Kathleen Hoffman, PhD, MSPH Humans evolved in a storytelling milieu where stories taught and explained the world around us. Our brains carry this legacy, [...]
Getting the Most from Online Surveys
Getting the Most from Online Surveys By Kathleen Hoffman, PhD, MSPH Do you wonder about online surveys? Are they reliable? Is there bias? A recent article by the Pew Research Center [...]
Getting the Most from Clinical Trial Protocol Feasibility Studies
Getting the Most from Clinical Trial Protocol Feasibility Studies By Monica St Claire Webinar provides expert tips for getting real feasibility data, optimizing trial design When the drug development process is [...]
Do You Really Know How Patients Talk About Their Condition?
Do You Really Know How Patients Talk About Their Condition? By Kathleen Hoffman, PhD MSPH There are classic examples of advertising messages that ended up offending the target customer, but the [...]
Do Patients Care About What Your Drug Does?
Do Patients Care About What Your Drug Does? By Sara Ray, MA Be sure the trial outcomes echo the patient voice, article says In most randomized pharmaceutical clinical trials, researchers are [...]
Clinical Trials and PROs: What Patients with Rare Diseases Say
Clinical Trials and PROs: What Patients with Rare Diseases Say By Kathleen Hoffman, PhD MSPH Challenges to developing clinical trials for rare diseases begin with their rarity – each condition affects [...]
What Members Tell Each Other About Clinical Trials
What Members Tell Each Other About Clinical Trials By Kathleen Hoffman, PhD MSPH "Failing to enroll a sufficient number of subjects in a trial is a long-standing problem"1 but understanding the [...]
Real World Data to Real World Evidence
Real World Data to Real World Evidence By Kathleen Hoffman, PhD MSPH You’ve started a medication, and you feel “off” in some way. How “off” do you have to feel before [...]